全文获取类型
收费全文 | 101193篇 |
免费 | 9435篇 |
国内免费 | 5786篇 |
专业分类
耳鼻咽喉 | 1026篇 |
儿科学 | 1568篇 |
妇产科学 | 1108篇 |
基础医学 | 10689篇 |
口腔科学 | 1855篇 |
临床医学 | 13115篇 |
内科学 | 14423篇 |
皮肤病学 | 1667篇 |
神经病学 | 4638篇 |
特种医学 | 4173篇 |
外国民族医学 | 45篇 |
外科学 | 9390篇 |
综合类 | 17549篇 |
现状与发展 | 22篇 |
一般理论 | 20篇 |
预防医学 | 8514篇 |
眼科学 | 2226篇 |
药学 | 11197篇 |
92篇 | |
中国医学 | 6065篇 |
肿瘤学 | 7032篇 |
出版年
2024年 | 322篇 |
2023年 | 1368篇 |
2022年 | 3461篇 |
2021年 | 4695篇 |
2020年 | 3560篇 |
2019年 | 2975篇 |
2018年 | 3133篇 |
2017年 | 3148篇 |
2016年 | 3045篇 |
2015年 | 4779篇 |
2014年 | 5925篇 |
2013年 | 6062篇 |
2012年 | 8956篇 |
2011年 | 9189篇 |
2010年 | 6616篇 |
2009年 | 5475篇 |
2008年 | 6497篇 |
2007年 | 6170篇 |
2006年 | 6012篇 |
2005年 | 5181篇 |
2004年 | 3817篇 |
2003年 | 3492篇 |
2002年 | 2964篇 |
2001年 | 1782篇 |
2000年 | 1473篇 |
1999年 | 1210篇 |
1998年 | 666篇 |
1997年 | 734篇 |
1996年 | 540篇 |
1995年 | 513篇 |
1994年 | 445篇 |
1993年 | 287篇 |
1992年 | 339篇 |
1991年 | 295篇 |
1990年 | 244篇 |
1989年 | 154篇 |
1988年 | 143篇 |
1987年 | 122篇 |
1986年 | 93篇 |
1985年 | 81篇 |
1984年 | 80篇 |
1983年 | 33篇 |
1982年 | 34篇 |
1981年 | 33篇 |
1980年 | 24篇 |
1979年 | 23篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1974年 | 16篇 |
1973年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
L H Ren A V Vasil'ev A N Orkehov V V Tertov V A Tutel'ian 《Farmakologiia i toksikologiia》1989,52(5):44-46
Administration of alizole, berberine, pheonol and pheoniphlorine in doses of 30-100 micrograms/ml in the culture of the atherosclerotic human aortic intimal cells decreased the content of intracellular cholesterol by 35-41% and reduced the proliferative activity of the cells. In healthy donors administration of single doses of berberine and pheoniphlorine (0.9 g) increased the antiatherogenic potential of the serum which was estimated on the primary culture of the intimal cells. 相似文献
42.
不同雾化吸入方式对婴幼儿支气管肺炎治疗效果的影响 总被引:1,自引:0,他引:1
分析病区库房物资管理中存在的问题,主要有管理意识缺乏,物资领取与临床需求脱节,医疗物资分配和使用不合理,物资的保管、维护不当。应对措施:加强医疗成本管理意识;物资领取时注意计划性和灵活性相结合;库房物资使用时注意原则性和节约性相结合;库房物资规范存放,做好各类固定资产的维护、保养管理;健全病区库房管理规章制度;树立科学发展观。 相似文献
43.
本中心对129例经腹腔镜证实为美国生殖医学会(ASRM)II-IV期子宫内膜异位症(内异症)合并其他不育因素而行体外受精-胚胎移植(IVF-ET)治疗的病例,进行了回顾性统计和分析。一、资料和方法1.临床资料:从2005年4月至2007年3月,在本中心接受IVF-ET治疗经腹腔镜证实为ASRMII-IV期内异症合并其他不育因素的129个周期病例;对照组为输卵管性不育的1,543个周期。内异症组根据有无促性腺激素释放激素激动剂(GnRH-a)药物降调节分为A、B两组进行分析,A组:中重度内异症在手术后接受长效GnRH-a(3.75 mg/支,每28 d一支,共2~6支)抑制治疗的39个… 相似文献
44.
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. 总被引:3,自引:0,他引:3
Pavel Sova Xiao-Wei Ren Shaoheng Ni Kathrin M Bernt Jie Mi Nancy Kiviat André Lieber 《Molecular therapy》2004,9(4):496-509
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The Ad capsid contains short-shafted fibers derived from Ad serotype 35, which allow for efficient infection of malignant tumor cells, and largely avoids innate toxicity after intravenous application. Replication-dependent homologous recombination in Ad genomes was used to achieve tumor-specific expression of Ad E1a (to mediate viral replication) and TRAIL (to mediate apoptosis and enhance release of progeny virus from infected cells). We demonstrated that our oncolytic vector (Ad5/35.IR-E1A/TRAIL) induced apoptosis in human tumor cell lines derived from colorectal, lung, prostate, and liver cancer. Both in vitro and in vivo tumor models showed efficient intratumoral spread of this vector. In a model for metastatic colon cancer, tail vein infusion of Ad5/35.IR-E1A/TRAIL resulted in elimination of preestablished liver metastases. Intravenous injection of this vector caused a transient elevation of serum glutamic pyruvic transaminase in tumor-bearing mice, which we attributed to factors released from apoptotic tumor cells. Liver histology analyzed at day 14 after virus injection did not show signs of hepatocellular damage. This new oncolytic vector represents a potentially efficient means for gene therapy of metastatic cancer. 相似文献
45.
咽旁间隙原发性肿块流行病学分析 总被引:1,自引:0,他引:1
目的:对咽旁间隙原发性肿块进行流行病学分析。方法:对咽旁间隙原发性239例肿块进行统计分析。结果:原发良性肿瘤患病比为61.09%,其中上皮源性肿瘤患病比最高,占19.25%;神经源性肿瘤第二位,占17.57%。原发性恶性肿瘤的患病比为35.15%,其中上皮源性恶性肿瘤的患病比最高,占21.76%;恶性淋巴瘤第2位,占7.95%。炎症的患病比为3.77%,其中淋巴结反应性增生最高。结论:咽旁间隙原发性肿块良性肿瘤的患病比最高,恶性肿瘤次之,炎症居第3位,比例约为17:9:1。 相似文献
46.
47.
Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate. 总被引:1,自引:0,他引:1
Romain Dayer Isabelle Badoud René Rizzoli Patrick Ammann 《Journal of bone and mineral research》2007,22(10):1526-1533
Protein deficiency is associated with impaired titanium osseointegration. We studied whether systemic treatment with PTH or pamidronate could influence the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. PTH or pamidronate prevented the deleterious effects of protein undernutrition on bone microarchitecture close to the implant and on mechanical fixation. PTH even significantly improved implant osseointegration. INTRODUCTION: Protein deficiency is highly prevalent among elderly patients hospitalized in orthopedic wards. Reduced protein intake impairs titanium osseointegration in rats. Whether stimulator of bone formation or inhibitor of bone resorption could improve implant osseointegration under protein deprivation is not known. We studied the effects of systemic treatment with PTH or pamidronate on the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. MATERIALS AND METHODS: We measured the resistance to pull-out 1-mm-diameter titanium rods implanted into the proximal tibias of 49 adult female rats receiving a normal or an isocaloric low protein diet. After 2 wk on either diet, the implants were inserted, and the rats received PTH(1-34), pamidronate or saline vehicle for 8 wk. The tibias were removed for microCT morphometry, followed by the evaluation of pull-out strength. RESULTS: Pull-out strength was lower in rats fed an isocaloric low protein diet compared with rats fed a normal protein intake (-29%). PTH and pamidronate significantly increased pull-out strength in animals fed a normal or a low protein diet, the effect of PTH being of higher magnitude. The PTH- or pamidronate-mediated increase in pull-out strength was associated with significant increases of relative bone volume, bone-to-implant contact, and trabecular thickness, whereas trabecular spacing was reduced, in the vicinity of the implants. CONCLUSIONS: We confirmed that isocaloric low protein intake impairs titanium implant osseointegration. PTH or pamidronate prevented the deleterious effects of protein undernutrition and even significantly improved the implant osseointegration. These results indicate that systemic administration of PTH or pamidronate could be considered for preventing uncemented arthroplasty loosening in protein undernourished patients. 相似文献
48.
唇腭裂患者上颌骨牵引成骨术后发音方式的变化 总被引:1,自引:0,他引:1
目的:通过对行颅外支架式上颌骨牵引成骨术(rigidexternaldistraction,RED)唇腭裂患者治疗前后的错误发音数量变化、不同发音部位、不同发音方法以及不同类型错误发音发生特点及其变化评价,分析上颌骨RED对患者发音方式的影响。方法:1999年至2001年行上颌骨RED的唇腭裂术后上颌发育不足患者21例,其中男性13例,女性8例,平均年龄15.05岁。所有患者RED前后进行语音测听并分类。治疗前后错误发音的差异性用非参数检验。结果:RED术后42.9%患者错误发音数较RED前增加,19.0%减少,38.1%无变化。从发音部位,舌尖前音错误发音发生率最高,其次为舌面音。从发音方法,错误发音多发于塞擦音。错误发音类型以咽喉摩擦/爆破音为主,其次为腭化构音和声门爆破音。上颌骨RED后腭化构音累及音节数减少,但咽喉摩擦/爆破音和声门爆破音反而增加,尤其是咽喉摩擦/爆破音。结论:唇腭裂患者经RED前移上颌骨后,会对患者发音方式产生影响,在行语音治疗前需考虑全面。 相似文献
49.
50.
Jacobo E Mintzer Larry E Tune Christopher D Breder René Swanink Ronald N Marcus Robert D McQuade Andy Forbes 《The American journal of geriatric psychiatry》2007,15(11):918-931
OBJECTIVE: To assess the efficacy and safety of aripiprazole for psychosis associated with Alzheimer dementia (AD). METHODS: In this double-blind, multicenter study, 487 institutionalized patients with psychosis associated with AD were randomized to placebo or aripiprazole, 2, 5 or 10 mg/day. Primary efficacy assessment was the mean change from baseline to week 10 on the Neuropsychiatric Inventory-Nursing Home (NPI-NH) version Psychosis Subscale score. Secondary measures included NPI-NH Total, Clinical Global Impression-Severity of Illness (CGI-S), Brief Psychiatric Rating Scale (BPRS) Core and Total, and the Cohen-Mansfield Agitation Inventory (CMAI) scores. RESULTS: Aripiprazole 10 mg/day showed significantly greater improvements (mean change [2 x SD]) than placebo on the NPI-NH Psychosis Subscale (-6.87 [8.6] versus -5.13 [10.0]; F = 6.29, df = 1, 422, p = 0.013 by analysis of covariance [ANCOVA]); CGI-S (-0.72 [1.8] versus -0.46 [1.6]; F = 4.68, df = 1, 419, p = 0.031 [ANCOVA]); BPRS Total (-7.12 [18.4] versus -4.17 [21.6]; F = 4.72, df = 1, 399, p = 0.030 [ANCOVA]); BPRS Core (-3.07 [6.9] versus -1.74 [7.8]; F = 7.30, df = 1, 407, p = 0.007 [ANCOVA]); CMAI (-10.96 [22.6] versus -6.64 [28.6]; F = 5.23, df = 1, 410, p = 0.023 [ANCOVA]), and NPI-NH Psychosis response rate (65 versus 50%; chi(2) = 5.52, df = 1, p = 0.019 [CMH]). Aripiprazole 5 mg/day showed significant improvements versus placebo on BPRS and CMAI scores. Aripiprazole 2 mg/day was not efficacious. Cerebrovascular adverse events were reported: aripiprazole 2 mg/day, N = 1; 5 mg/day, N = 2; 10 mg/day, N = 4; placebo, N = 0. No deaths in any group (aripiprazole 2 mg/day, 3%; 5 mg/day, 2%; 10 mg/day, 7%; placebo, 3%) were considered to be treatment-related. CONCLUSION: Aripiprazole 10 mg/day was efficacious and safe for psychosis associated with AD, significantly improving psychotic symptoms, agitation, and clinical global impression. However, clinicians should be aware of the safety considerations of atypical antipsychotic uses in this population. 相似文献